Latest Gross Margins News

Vitura Health grew FY2026 revenue 6% to $131.2 million, but a sharp margin squeeze pushed the ASX-listed digital health company into a $4.4 million statutory loss. With ANZ debt classified as current and a potential $6 million FY2027 revenue hit from changed Bupa referrals, the promised turnaround faces a demanding test.

Shaver Shop Group Limited (ASX:SSG) delivered record FY2026 sales, gross profit and operating cash flow, but flagged a softer-than-expected start to the new financial year. Transform-U reached $18 million in sales, while supplier logistics issues and promotional timing weighed on early FY2027 trading.

Dusk Group has carried its FY26 momentum into the new financial year, with like-for-like sales up 7.2% in the first 15 weeks despite operating six fewer stores. The home-fragrance retailer is now preparing a tightly controlled South African launch while an unresolved ACCC court case remains a material complication.

DroneShield has reached A$261 million in FY2026 Committed Revenue, sitting at the midpoint of its existing A$250 million to A$270 million outlook. The counter-drone specialist also has A$29 million committed for FY2027 and A$17 million scheduled for FY2028 and beyond.

Locality Planning Energy has returned to statutory profit and sharply reduced borrowings, but its next test is converting a large contracted pipeline into active service points. The company has given no numerical FY2027 guidance and is operating under an interim leadership structure while it searches for a permanent CEO.

Bubs Australia delivered 9.2% revenue growth and a sharp underlying EBITDA improvement in FY26, but statutory losses, weaker margins and negative operating cash flow expose the cost of its expansion. Permanent US FDA authorisation removes a major regulatory hurdle, while the annual report still flags material uncertainty around ongoing funding and cash generation.

Elixinol Wellness lifted Q3 gross profit 27% and delivered a fourth consecutive quarter of positive underlying operating cash flow, despite statutory operating cash flow remaining negative and cash below A$1 million. The proposed all-scrip Vitable acquisition could add scale, but shareholder approval and a thin liquidity buffer remain important next tests.

Bailador Technology Investments reported $28 million in FY26 cash realisations and 32% weighted revenue growth across its portfolio, while profit after tax fell to $6.9 million. The technology investment fund also reaffirmed its fully franked dividend strategy despite a 7.5% gross portfolio return that fell short of internal targets.

Carbonxt has added four US waste-to-energy facilities to its Reworld supply agreement, lifting annual Powdered Activated Carbon volumes by about 25% from January 2027. The expanded contract pushes the company’s FY27 revenue expectation to at least 40% above FY26, while Kentucky remains outside the forecast.

Elixinol Wellness has lifted combined hemp sales 12% to $6.41 million in the first nine months of 2026, while unaudited gross profit rose 41%. Two major grocery programs are now fully supplied through 2027, with Hemp Gold Protein due back at Costco in Australia and New Zealand.

Baby Bunting has reaffirmed its FY27 earnings and sales targets despite underlying comparable store sales growth moderating to 2.2% in the first 14 weeks. The retailer says its Store of the Future refurbishments are now delivering a 20% average sales uplift across 17 stores.

WiseTech Global’s FY26 annual report charts a year of extraordinary expansion, with revenue up 79% after the e2open acquisition and underlying EBITDA up 56%. But the stronger earnings base comes with heavier debt, a major workforce reset and unresolved regulatory risks.